- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x CYS: CYSTEINE(Non-covalent)
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
FBP.2: 16 residues within 4Å:- Chain A: L.451, T.452, K.453, S.454, R.456, S.457, W.502, R.509, G.534, R.536, P.537, G.538, S.539, G.540, F.541, T.542
15 PLIP interactions:15 interactions with chain A- Hydrogen bonds: A:T.452, A:K.453, A:S.454, A:G.455, A:R.456, A:S.457, A:S.457, A:G.534, A:R.536, A:G.538, A:G.540, A:F.541, A:F.541
- Salt bridges: A:K.453, A:R.509
FBP.7: 18 residues within 4Å:- Chain B: L.451, T.452, K.453, S.454, G.455, R.456, S.457, W.502, R.509, G.534, W.535, R.536, P.537, G.538, S.539, G.540, F.541, T.542
16 PLIP interactions:16 interactions with chain B- Hydrogen bonds: B:T.452, B:K.453, B:S.454, B:G.455, B:S.457, B:G.534, B:G.534, B:G.538, B:G.540, B:F.541
- Water bridges: B:R.509, B:R.509, B:T.542, B:T.542
- Salt bridges: B:K.453, B:R.509
FBP.11: 17 residues within 4Å:- Chain C: L.451, T.452, K.453, S.454, R.456, S.457, W.502, R.509, T.533, G.534, R.536, P.537, G.538, S.539, G.540, F.541, T.542
16 PLIP interactions:16 interactions with chain C- Hydrogen bonds: C:T.452, C:T.452, C:K.453, C:S.454, C:G.455, C:S.457, C:S.457, C:S.457, C:R.509, C:G.534, C:G.538, C:G.540, C:F.541, C:F.541
- Salt bridges: C:K.453, C:R.509
FBP.16: 17 residues within 4Å:- Chain D: L.451, T.452, K.453, S.454, G.455, R.456, S.457, W.502, R.509, G.534, R.536, P.537, G.538, S.539, G.540, F.541, T.542
15 PLIP interactions:15 interactions with chain D- Hydrogen bonds: D:T.452, D:T.452, D:K.453, D:S.454, D:G.455, D:S.457, D:S.457, D:G.534, D:R.536, D:G.538, D:G.540, D:F.541
- Water bridges: D:R.509, D:T.542
- Salt bridges: D:R.509
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.3: 3 residues within 4Å:- Chain A: E.292, D.316
- Ligands: OXL.4
4 PLIP interactions:2 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: A:E.292, A:D.316, H2O.2, H2O.3
MG.8: 3 residues within 4Å:- Chain B: E.292, D.316
- Ligands: OXL.9
4 PLIP interactions:2 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: B:E.292, B:D.316, H2O.9, H2O.11
MG.12: 3 residues within 4Å:- Chain C: E.292, D.316
- Ligands: OXL.13
4 PLIP interactions:2 interactions with chain C, 2 Ligand-Water interactions- Metal complexes: C:E.292, C:D.316, H2O.15, H2O.17
MG.17: 3 residues within 4Å:- Chain D: E.292, D.316
- Ligands: OXL.18
4 PLIP interactions:2 interactions with chain D, 2 Ligand-Water interactions- Metal complexes: D:E.292, D:D.316, H2O.21, H2O.21
- 4 x OXL: OXALATE ION(Non-covalent)
OXL.4: 9 residues within 4Å:- Chain A: R.93, K.290, E.292, A.313, R.314, G.315, D.316, T.348
- Ligands: MG.3
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:G.315, A:D.316, A:D.316
- Water bridges: A:R.93, A:K.290
- Salt bridges: A:R.93, A:K.290, A:K.290
OXL.9: 9 residues within 4Å:- Chain B: K.290, E.292, M.311, A.313, R.314, G.315, D.316, T.348
- Ligands: MG.8
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:G.315, B:D.316, B:T.348, B:T.348, B:T.348
- Salt bridges: B:R.93, B:K.290, B:K.290
OXL.13: 8 residues within 4Å:- Chain C: K.290, E.292, A.313, R.314, G.315, D.316, T.348
- Ligands: MG.12
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:E.292, C:E.292, C:G.315, C:D.316
- Water bridges: C:K.290
- Salt bridges: C:R.93, C:K.290
OXL.18: 8 residues within 4Å:- Chain D: K.290, E.292, A.313, R.314, G.315, D.316, T.348
- Ligands: MG.17
8 PLIP interactions:8 interactions with chain D- Hydrogen bonds: D:E.292, D:E.292, D:E.292, D:G.315, D:D.316
- Water bridges: D:K.290
- Salt bridges: D:R.93, D:K.290
- 2 x K: POTASSIUM ION(Non-covalent)
K.5: 6 residues within 4Å:- Chain A: N.95, S.97, D.133, T.134, S.263, K.290
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:S.97, A:D.133, A:T.134
K.14: 6 residues within 4Å:- Chain C: N.95, S.97, D.133, T.134, S.263, K.290
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:S.97
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Srivastava, D. et al., Mechanistic and Structural Insights into Cysteine-Mediated Inhibition of Pyruvate Kinase Muscle Isoform 2. Biochemistry (2019)
- Release Date
- 2019-08-21
- Peptides
- Pyruvate kinase PKM: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
AC
BD
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.25 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x CYS: CYSTEINE(Non-covalent)
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x OXL: OXALATE ION(Non-covalent)
- 2 x K: POTASSIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Srivastava, D. et al., Mechanistic and Structural Insights into Cysteine-Mediated Inhibition of Pyruvate Kinase Muscle Isoform 2. Biochemistry (2019)
- Release Date
- 2019-08-21
- Peptides
- Pyruvate kinase PKM: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DB
AC
BD
C